George B. Breen, Member of the Firm in the Health Care & Life Sciences and Litigation practices and Chair of the firm’s National Health Care & Life Sciences Practice Steering Committee, in the firm’s Washington, DC, office, offers a prediction of what is to come as the U.S. Supreme Court hears oral arguments in a case disputing whether the federal government has the authority to unilaterally dismiss False Claims Act lawsuits filed by whistleblowers.
Following is an excerpt:
For more information, please read “SCOTUS Considers DOJ's Ability to Dismiss FCA Qui Tam Suits,” by Katie Pasek, Reuters Westlaw.
People
- Board of Directors / Member of the Firm